Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.1.1.62 extracted from

  • Luzhkov, V.B.; Selisko, B.; Nordqvist, A.; Peyrane, F.; Decroly, E.; Alvarez, K.; Karlen, A.; Canard, B.; Qvist, J.
    Virtual screening and bioassay study of novel inhibitors for dengue virus mRNA cap (nucleoside-2O)-methyltransferase (2007), Bioorg. Med. Chem., 15, 7795-7802.
    View publication on PubMed

Inhibitors

Inhibitors Comment Organism Structure
N-[[3-(4-methylphenyl)adamant-1-yl]carbamoyl]-L-phenylalanine 0.1 mM, 75% inhibition. It is suggested that the inhibitor competes with the cofactor AdoMet and presumably also the capped RNA substrate Dengue virus

Organism

Organism UniProt Comment Textmining
Dengue virus
-
-
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
S-adenosyl-L-methionine + 7MeGpppAC5 RNA substrate is used Dengue virus S-adenosyl-L-homocysteine + 7MeGpppA2'OMeC5
-
?

Synonyms

Synonyms Comment Organism
mRNA cap (nucleoside-2'O)-methyltransferase
-
Dengue virus
NS5MTaseDV
-
Dengue virus

Cofactor

Cofactor Comment Organism Structure
AdoMet
-
Dengue virus

IC50 Value

IC50 Value IC50 Value Maximum Comment Organism Inhibitor Structure
0.0605
-
-
Dengue virus N-[[3-(4-methylphenyl)adamant-1-yl]carbamoyl]-L-phenylalanine